China · Delayed Price · Currency is CNY Hubei Hongyuan Pharmaceutical Technology Company Description
Hubei Hongyuan Pharmaceutical Technology Co., Ltd., together with its subsidiaries, produces and sells pharmaceutical products in China and internationally.
The company offers active pharmaceutical ingredients, such as metronidazole, benzoyl metronidazole, dimetrizole, and acyclovir; pharmaceutical intermediates, including imidazole, glyoxylic acid, 2-methyl imidazole, 2-methyl-5-nitroimidazole, sulfate, guanine, diacetyl guanine, and diacetylacyclovir; organic chemical raw materials comprising glyoxal, and oxalic acid; and new energy materials consisting of lithium hexafluorophosphate.
It also is involved in the production and sales of triamines, guanine and other products; research and development, production, and sales of pharmaceutical preparations; trading of APIS, pharmaceutical intermediates, organic chemical raw materials, etc.; fluoride salts and other fluorine-containing chemical products; and pharmaceutical wholesale, retail, etc. Hubei Hongyuan Pharmaceutical Technology Co., Ltd. was founded in 2002 and is headquartered in Huanggang, China.
| Country | China |
| Founded | 2002 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,169 |
| CEO | Shuangxi Xu |
Contact Details
Address: No.8 Hongyuan Road Huanggang, 438600 China | |
| Phone | 86 71 3510 9598 |
| Website | hbhypharm.com |
Stock Details
| Ticker Symbol | 301246 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Shuangxi Xu | Director and General Manager |
| Kefeng Zeng | Financial Director |
| Yonghua Xiao | Director, Secretary of the Board and Accounting Supervisor |
| Zhihua Deng | Deputy GM and Non-Independent Director |
| Siyuan Cheng | Deputy GM and Non-Independent Director |